Medicxi Ventures Management (Jersey) Ltd 13F Holdings · Q2 2026
Medicxi Ventures Management (Jersey) Ltd reported 3 securities worth $177.42M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: PHAT (45.65%), NAMS (42.19%), AURA (12.16%). Among its top 25 positions this quarter: 1 trimmed, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PHAT | PHATHOM PHARMACEUTICALS INC | $81.0M | 45.65% | 7.5M | Hold |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $74.9M | 42.19% | 2.2M | Trimmed |
| 3 | AURA | AURA BIOSCIENCES INC | $21.6M | 12.16% | 3.0M | Hold |
| 4 | CNTA | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR